Data from Bayer’s cardiovascular portfolio in heart failure and cardiac amyloidosis will be presented, including ...
Watching the baseball playoffs this week, I was struck by the parallels between the Los Angeles Dodgers and Eli Lilly. Both ...
Leveraging recently proposed regulatory flexibilities, the gene-editing sector is working to cut R&D costs and unlock ...
With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.
October 8, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") announces the ...
October 8, 2026) - Zenith Epigenetics Ltd. ("Zenith" or the "Company") today announced that the Company has received clearance from the US Food and Drug Administration ("FDA") to sponsor a ...
Grant in Mexico marks a major milestone in global IP strategy, advancing protection of its VIVI Box platform across key ...
Argenx shares have fallen more than 13% after the surprise futility finding, which overshadowed a mid-stage celiac disease ...
After one patient death prompted an FDA hold this spring, Newron Pharmaceuticals has now shared that a total of four ...
Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbers
For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 ...
Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, ...
Iantrek, Inc., a company pioneering bio-interventional ophthalmic surgery (BIOS), today announced topline six-month results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results